GLG News by Ophthalmologists
Request a free trial
July 30, 2007JSM 6427: the new face of armd therapy
Analysis of: FDA Accepts Jerini Ophthalmic's IND of JSM 6427 for the Treatment of AMD | www.pipelinereview.com
Author: Gaurav Shah, Associate Professor of Ophthalmology, Washington University Medical Center
1. A molecule that allows on to stop neovascular armd to form from dry armd 2. A product with a potentially large market share compared to the current agents available 3. A compound that could have a sustained drug delivery module
July 30, 2007
Will Bausch & Lomb (BOL) Accept AMO's (EYE) Better Bid?
Analysis of: Bausch & Lomb likely to reject AMO takeover bid | www.osnsupersite.com
Author: GLG Expert Contributor
Analysis of: Bausch & Lomb likely to reject AMO takeover bid | www.osnsupersite.com
Author: GLG Expert Contributor
Bausch & Lomb (BOL) is in a bidding war with a private equity firm (Warburg Pincus) and Advanced Medical Optics (EYE). AMO's Bid is $10 higher (15% Premium) and appeals to be superior but there is unclear resistance which may lead to its denial. The implications could significantly impact...
July 30, 2007
Monovision WILL NOT solve the Presbyopia problem.
Analysis of: Monovision promising for presbyopia correction in cataract patients, surgeon says | www.osnsupersite.com
Author: GLG Expert Contributor
Analysis of: Monovision promising for presbyopia correction in cataract patients, surgeon says | www.osnsupersite.com
Author: GLG Expert Contributor
This small study involving 14 patients claims that monovision may help correct presbyopia in cataract patients. This concept is nothing new as monovision through contact lens, refractive surgery (LASIK) or intraocular lenses (IOLs) has been around for years. Monovision is only tolerated...
July 30, 2007
AMO overtakes Bausch and Lomb; Unlikely
Analysis of: AMO outbids private equity firm for Bausch & Lomb | www.osnsupersite.com
Author: GLG Expert Contributor
Analysis of: AMO outbids private equity firm for Bausch & Lomb | www.osnsupersite.com
Author: GLG Expert Contributor
AMO's VISX has about 50% of the excimer laser business. B&L has the number 2 spot with about 25% of the market share. A take over by AMO could pose a monopoly in the laser market, that can hinder innovation.
July 30, 2007
Custom laser able to deliver monovision.
Analysis of: FDA Approves Bifocal LASIK Surgery | www.medpagetoday.com
Author: GLG Expert Contributor
Analysis of: FDA Approves Bifocal LASIK Surgery | www.medpagetoday.com
Author: GLG Expert Contributor
Custom lasers were unable to achieve monovision in the past since hey capture and treat the whole refractive error of the eye. The ability to perform monovision in a custom platform will make easier for practices to offer more custom procedures to the 40+ patients, thus translating into higher...
July 30, 2007
Bilateral Cataracts are Associated with Better Visual Outcomes than Unilaterl Cataracts in Children.
Analysis of: Study: Better visual outcomes from bilateral cataract surgery in children | www.osnsupersite.com
Author: GLG Expert Contributor
Analysis of: Study: Better visual outcomes from bilateral cataract surgery in children | www.osnsupersite.com
Author: GLG Expert Contributor
This retrospective study affirms the previous thoughts about amblyopia in children. Children with bilateral cataracts should have both cataracts removed as soon as possible to minimize the effects of amblopia and maintain normal visual development. The implications for the marketplace for cataract...
July 26, 2007
CVS/Pharmacy stores for medical basic assistence.
Analysis of: An Innovation in Health Care Opens at CVS/Pharmacy Stores in Knoxville and Chattanooga | money.cnn.com
Author: GLG Expert Contributor
Analysis of: An Innovation in Health Care Opens at CVS/Pharmacy Stores in Knoxville and Chattanooga | money.cnn.com
Author: GLG Expert Contributor
1. Medical asistance. 2. Health unexpensiveness. 3. Posibility of multiple medical offices. 4. Quality of services.
July 25, 2007
Smart move
Analysis of: Alcon Announces Offer for WaveLight AG | invest.alconinc.com
Author: GLG Expert Contributor
Analysis of: Alcon Announces Offer for WaveLight AG | invest.alconinc.com
Author: GLG Expert Contributor
ALCON has real chance in expanding its laser refractive market share. Getting rid of a less than optimal platform and replacing it with the Allegretto laser has excellent potential for ALCON.
July 25, 2007
Alcon with Alegretto can satisfy LASIK surgeons
Analysis of: Alcon Announces Offer for WaveLight AG | invest.alconinc.com
Author: GLG Expert Contributor
Analysis of: Alcon Announces Offer for WaveLight AG | invest.alconinc.com
Author: GLG Expert Contributor
Alcon has had recent problems with its LadarVision device. Surgeons not previously exposed to the Alegretto machine have been pleasantly surprised. The Alegretto is easy to use, fast and accurate. While Alcon will initially compete with itself, marketing two devices, it will keep surgeons...
July 25, 2007Cell Transfer Device for Corneal Wound Healing
Analysis of: New Method Of Adult Stem Cell Growth Treats Cornea Disorders | www.sciencedaily.com
Author: Paul Chen, Ophthalmologist, North County Laser Eye Associates
I have been working on a cell transfer device designed to optimize wound healing after PRK laser vision correction. Essentially, we plan to coat a silicone hydrogel contact lens with a thin dissolvable layer of collagen on the concave surface. Cultured epithelial cells would be seeded onto the collagen...
Previous Page : 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Next71 to 80 of 158
More GLG News in
Healthcare
Most Popular:
Source Article | Expert Analyses
Use of Antipsychotics in Children Is Criticized
www.nytimes.com
Scientists recommend 'black box' for Avastin
www.fiercepharma.com
Are Costly Diabetes Pills Doing Any Good?
www.pharmalot.com
How a Drug Maker Tries to Outwit Generics
online.wsj.com
Use of Antipsychotics in Children Poses Risks of Adverse Effects
November 26, 2008
Avastin and clots? News to me. Black box warning? Why?
November 24, 2008
Off Label Use Can Be Prevented
November 24, 2008
Gardasil will most certainly be approved for boys
November 24, 2008
Medivations's (MDVN) Dimebon - We've Seen This Movie Before
November 24, 2008

